Menthol Cigarette Report
|
|
- Domenic Hampton
- 5 years ago
- Views:
Transcription
1 Menthol Cigarette Report Tobacco Products Scientific Advisory Committee Meeting July 15, 2010 Corinne G. Husten, MD, MPH Senior Medical Advisor Center for Tobacco Products, FDA 1
2 Menthol Cigarette Report 907(e)(1): Immediately upon the establishment of TPSAC, the Secretary shall refer to the Committee for report and recommendation the issue of the impact of the use of menthol in cigarettes on the public health, including such use among children, African Americans, Hispanics, and other racial and ethnic minorities 2
3 Menthol Cigarette Report 907(e)(2): Not later than 1 year after its establishment, the TPSAC shall submit to the Secretary the required report and recommendations Menthol Report due: March 23,
4 Review of the March TPSAC Meeting Presentations of published research on Use of menthol cigarettes by demographic groups Menthol cigarettes and smoking initiation Marketing of menthol cigarettes and consumer perceptions Menthol cigarette sensory qualities, topography Menthol s effect on nicotine dependence Menthol cigarettes and smoking cessation behavior Health effects of mentholated cigarettes 4
5 July TPSAC Meeting Industry presentations on five topics: Characterization of menthol in cigarettes Clinical effects of menthol cigarettes Biomarkers of disease risk for menthol cigarette smokers Marketing data on menthol cigarettes Population effects of menthol cigarettes 5
6 Areas of Interest Identified by the Committee Characterization of Menthol Trends in quantities of menthol present in the cigarette rod and smoke over time for various brands/subbrands of menthol and nonmenthol products as determined by the Cambridge Filter/ISO test method using standard parameters as well as the intense smoking conditions set forth in Canadian regulations Information regarding the manufacturing of menthol cigarettes, including Source and type of menthol used Presence or use of any menthol analogs* Types of manufacturing processes through which menthol is introduced into the tobacco product, as well as the considerations in selecting a particular method *FDA added this request of Industry 6
7 Areas of Interest Identified by the Committee Characterization of Menthol Threshold (menthol content) at which a product is identified and marketed as a menthol cigarette Rationale for adding menthol to cigarettes not marketed as menthol cigarettes, and the criteria for determining quantity of menthol to be added International brands of menthol cigarettes, the quantities of menthol in both menthol and nonmenthol cigarettes sold internationally, and the factors considered in determining the quantity of menthol to be added 7
8 Areas of Interest Identified by the Committee Clinical Effects of Menthol Studies of dose-response relationships for the physiologic effects of mentholated tobacco smoke Mechanistic studies of menthol effects including Chemosensory effects of menthol compounds in tobacco smoke, including effects at thermal and trigeminal receptors Effect of menthol on the neurobiology of tobacco dependence Effect of menthol on clinical and behavioral measures 8
9 Areas of Interest Identified by the Committee Clinical Effects of Menthol Studies addressing the dosing relationship and the metabolic interactions between nicotine and menthol, including resulting perceptions of nicotine strength and the interaction between menthol delivery and nicotine/tar levels, for both low-menthol and high-menthol products Information on correlations between menthol content and consumer perceptions regarding Taste Nicotine strength Product harm 9
10 Areas of Interest Identified by the Committee Biomarkers Analyses of laboratory and populations studies using biomarkers to assess the effect of menthol content on disease risk for cigarette smokers, based on cigarette consumption (e.g., cigarettes per day), including data related to menthol among population subgroups 10
11 Areas of Interest Identified by the Committee Marketing Data Data on consumer preferences for menthol cigarettes Consumer perception studies of advertising and packaging of menthol cigarettes Marketing strategies for various brands / subbrands of menthol cigarettes, including strategies targeted to particular demographic groups Marketing strategies for various brands / subbrands of menthol cigarettes sold internationally 11
12 Areas of Interest Identified by the Committee Population Effects Among cigarette smokers, rates of switching from menthol to nonmenthol cigarettes and vice versa Comparative rates of initiation by youth and young adults for menthol and nonmenthol cigarettes Comparative rates of cessation for users of menthol and nonmenthol cigarettes 12
13 Update on Other Information Requested by Committee Members Request for industry documents sent 05/26/10 Mandatory and voluntary submissions due to FDA 08/26/10 In progress Analysis of publicly available internal tobacco industry documents White paper on the studies presented at the first meeting References have been updated with relevant articles suggested by industry representatives and others 13
14 Update on Other Information Requested by Committee Members Expect contract to be awarded shortly to: Fund secondary data analyses of existing research studies on initiation, cessation, addiction and health effects of cigarette use to assess the impact of menthol cigarettes on these measures Analyze menthol cigarette sales data Develop a statistical model of menthol cigarettes effects on initiation and cessation Support for the writing of the menthol report Plan to establish a menthol report subcommittee Report will be presented to TPSAC for review and approval 14
15 Clarifying Questions? 15
Tobacco-related risk perceptions in the regulation of tobacco products at the FDA Center for Tobacco Products
Tobacco-related risk perceptions in the regulation of tobacco products at the FDA Center for Tobacco Products David B. Portnoy, PhD, MPH Conrad J. Choiniere, PhD Office of Science FDA, Center for Tobacco
More informationRe: Docket No. FDA-2013-N-0521, Menthol in Cigarettes, Tobacco Products; Request for Comments
November 22, 2013 Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, rm. 1061 Rockville, MD 20852 Re: Docket No. FDA-2013-N-0521, Menthol in Cigarettes, Tobacco Products;
More informationMenthol Cigarettes, Smoking Cessation, Atherosclerosis and Pulmonary Function
Center for Regulatory Effectiveness (CRE) assessment of the following research report: Menthol Cigarettes, Smoking Cessation, Atherosclerosis and Pulmonary Function By: Mark J. Pletcher, MD, MPH; Benjamin
More informationTOBACCO USE AMONG AFRICAN AMERICANS
TOBACCO USE AMONG AFRICAN AMERICANS Each year, approximately 45,000 African Americans die from smoking-related disease. 1 Smoking-related illnesses are the number one cause of death in the African-American
More informationMenthol cigarettes are a public health problem
Menthol cigarettes are a public health problem ANDREA VILLANTI, PHD MPH JUNE 22, 2016 disclosures Andrea Director The Adjunct Department Johns Villanti, PhD, MPH, CHES for Regulatory Science and Policy
More informationElectronic Nicotine Delivery Systems: Patterns of Use and Disparities
Electronic Nicotine Delivery Systems: Patterns of Use and Disparities Daniel P. Giovenco, PhD, MPH Assistant Professor of Sociomedical Sciences Columbia University Mailman School of Public Health Outline
More informationComparisons Between Adult Menthol and Non-Menthol Smokers Total Exposure Study. Mohamadi Sarkar, M.Pharm., Ph.D Altria Client Services
Comparisons Between Adult and Non- Smokers Total Exposure Study ohamadi Sarkar,.Pharm., Ph.D Altria Client Services 1 Altria Client Services (on behalf of Philip orris USA) Presentation to the Tobacco
More informationDissolvable Tobacco Products
Dissolvable Tobacco Products James E. Dillard Senior Vice President, Regulatory Affairs Altria Client Services 1 l Altria Client Services (on behalf of PM USA and USSTC) I Presentation to the Tobacco Products
More informationCommunicating the Risk of Nicotine Delivery Products
Communicating the Risk of Nicotine Delivery Products August 10, 2014 ACS National Meeting Jim Solyst June 24, 2014 1 Nicotine Background Key Points The popularity of e-cigarettes has increased the need
More informationFDA Center for Tobacco Products: Tobacco Research and the Population Assessment of Tobacco and Health (PATH) Study
FDA Center for Tobacco Products: Tobacco Research and the Population Assessment of Tobacco and Health (PATH) Study Regulatory Public Laws Compliance & Education Policies Science & Enforcement & Communications
More informationThe Latest on Vaping Among U.S. Teens
The Latest on Vaping Among U.S. Teens Jon Macy, PhD, MPH Indiana University School of Public Health Bloomington Presentation Outline Overview of Electronic Nicotine Delivery Systems (ENDS) New Prevalence
More informationMitch Zeller, Director, Center for Tobacco Products, FDA September 19, 2013 Kansas Public Health Association
Regulatory Public Laws Compliance & Education Policies Science & Enforcement & Communications The FDA Center for Tobacco Products (CTP): Its Role in Reducing Tobacco Use Mitch Zeller, Director, Center
More informationMenthol and the Tobacco Products Scientific Advisory Committee
Tobacco, Menthol and the Tobacco Products Scientific Advisory Committee 2010 CBC Spring Health Braintrust/NMQF 7 th Annual Leadership Meeting The Ritz Carlton Hotel Washington, DC April 20, 2009 NAATPN
More informationWhere We Are: State of Tobacco Control and Prevention
Where We Are: State of Tobacco Control and Prevention Corinne Husten, MD, MPH Acting Director CDC Office on Smoking and Health Nova Scotia, Canada October 2006 Tobacco Impact Background Tobacco is leading
More informationUPDATE ON PREMARKET TOBACCO PRODUCT AUTHORIZATION PATHWAY
UPDATE ON PREMARKET TOBACCO PRODUCT AUTHORIZATION PATHWAY Presented by Ii-Lun Chen, M.D Director Division of Individual Health Science Office of Science, CTP, FDA Disclaimer: This is not a formal dissemination
More informationFDA s Action Agenda to Reduce Tobacco Related-Cancer Incidence and Mortality
FDA s Action Agenda to Reduce Tobacco Related-Cancer Incidence and Mortality Lawrence Deyton, M.S.P.H., M.D. Director, FDA Center for Tobacco Products June 11, 2012 FDA s Vision To make tobaccorelated
More informationGlobal E-Cigarette Market- Industry Analysis & Outlook ( )
Global E-Cigarette Market- Industry Analysis & Outlook (2016-2020) ----------------------------------------- Executive Summary Electronic cigarettes, also known as E-cigarettes, electronic nicotine delivery
More informationClinical Effects. Jane Y. Lewis, Ph.D. Senior Vice President, Health & Analytical Sciences Altria Client Services
Clinical Effects Jane Y. Lewis, Ph.D. Senior Vice President, Health & Analytical Sciences Altria Client Services 1 l Altria Client Services (on behalf of Philip Morris USA) l Presentation to the Tobacco
More informationMenthol and Cigarettes
Menthol and Cigarettes What is Menthol and How is it Used? Menthol is a naturally occurring compound derived from mint plants and is also synthetically produced. [1] Because of its cool, minty candy-like
More informationAre Menthol Cigarettes a Starter Product for Youth?
Posted For Public Comment May 7, 2010 Are Menthol Cigarettes a Starter Product for Youth? By: James C. Hersey, Shu Wen Ng, James M. Nonnemaker, Paul Mowery, Kristin Y. Thomas, My-Charllins Vilsaint, Jane
More informationMenthol Sensory Properties and Possible Effects on Topography
Menthol Sensory Properties and Possible Effects on Topography Deirdre Lawrence Ph.D., M.P.H. FDA Center for Tobacco Products on detail from National Cancer Institute (NCI) / NIH Tobacco Products Scientific
More informationACHIEVING SMOKEFREE AOTEAROA BY2025
ACHIEVING SMOKEFREE AOTEAROA BY2025 Monitoring and evaluation plan CONTENTS Acknowledgements 1 Introduction 2 Logic model 3 Sources of information 4 Monitoring progress towards the SFA 2025 goal 4 System
More informationCigarette Packaging in Ireland: The Plain Future.
http://www.cit.ie Cigarette Packaging in Ireland: The Plain Future. Wesley Connolly Tong and Maurice Murphy New Laws in Ireland Ireland has become the first country in Europe and the second in the world
More informationPeter G. Shields, MD Tobacco Products Scientific Advisory Committee (TPSAC) August 16, 2013
Peter G. Shields, MD Tobacco Products Scientific Advisory Committee (TPSAC) August 16, 2013 Conceptual Framework for Evaluating MRTPs: Objectives Provide a framework for evaluating all tobacco products
More informationMenthol cigarettes and the public health standard: a systematic review
Villanti et al. BMC Public Health (2017) 17:983 DOI 10.1186/s12889-017-4987-z RESEARCH ARTICLE Menthol cigarettes and the public health standard: a systematic review Open Access Andrea C. Villanti 1,2,3*,
More informationSTATE OF NEW JERSEY. ASSEMBLY, No th LEGISLATURE. Sponsored by: Assemblyman HERB CONAWAY, JR. District 7 (Burlington)
ASSEMBLY, No. STATE OF NEW JERSEY th LEGISLATURE INTRODUCED JANUARY, 0 Sponsored by: Assemblyman HERB CONAWAY, JR. District (Burlington) SYNOPSIS Prohibits sale of menthol cigarettes. CURRENT VERSION OF
More informationRE: Docket No. FDA-2014-N , Electronic Cigarettes and the Public Health
VIA ELECTRONIC SUBMISSION June 30, 2015 Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852 RE: Docket No. FDA-2014-N-1936-0001, Electronic
More informationFamily Smoking Prevention and Tobacco Control Act. Comments regarding crop protection agents
Family Smoking Prevention and Tobacco Control Act (PUBLIC LAW 111-31 JUNE 22, 2009) Comments regarding crop protection agents Presentation Objectives What is the intent of FDA in regulating CPAs? What
More informationPOSSIBLE REVISION OF THE TOBACCO PRODUCTS DIRECTIVE 2001/37/EC PUBLIC CONSULTATION DOCUMENT
POSSIBLE REVISION OF THE TOBACCO PRODUCTS DIRECTIVE 2001/37/EC DG SANCO 2010 PUBLIC CONSULTATION DOCUMENT Answer given by the General Direction of Public Health of the Spanish Ministry of Health and Social
More informationThe Modified Risk Products. or Protectionism?
The Modified Risk Products Provisions of the FDA Tobacco Act: Science Based Policy or Protectionism? Michael Siegel, MD, MPH Professor Boston University School of Public Health Who Am I? Testified in more
More informationThe Family Smoking Prevention and Tobacco Control Act s Grant of Authority to the FDA and the Impact on the Grower
The Family Smoking Prevention and Tobacco Control Act s Grant of Authority to the FDA and the Impact on the Grower Victor L. Moldovan McGuireWoods, LLP The Act The Act governs all manufacturers and importers
More informationAN UPDATE ON FDA S COMPREHENSIVE PLAN ON TOBACCO AND NICOTINE
AN UPDATE ON FDA S COMPREHENSIVE PLAN ON TOBACCO AND NICOTINE Mitch Zeller, J.D. Director, FDA May 3, 2018 CENTER FOR TOBACCO PRODUCTS HOW CAN WE MAKE THE GREATEST IMPACT? We truly find ourselves at a
More informationProblem Which option Additional option Additional comments definition Yes No change No further observations.
Department of Health, United Kingdom electronic contribution rec. 317 - by Mr Lee McGill lee.mcgill@dh.gsi.gov.uk Question 1 - scope Problem Which option Recommend option Additional comments Yes No change
More informationPUBLIC CONSULTATION DOCUMENT
EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Directorate C Public Health and Risk Assessment POSSIBLE REVISION OF THE TOBACCO PRODUCTS DIRECTIVE 2001/37/EC PUBLIC CONSULTATION DOCUMENT
More informationHow to Regulate E-Cigarettes? Are we asking the right questions?
How to Regulate E-Cigarettes? Are we asking the right questions? Eric N. Lindblom Director, Tobacco Control and Food & Drug Law O Neill Institute for National & Global Health Law Georgetown University
More informationTobacco & Mississippi Youth
Tobacco & Mississippi Youth Youth Tobacco Use Where we are now: 1998-2012 - Early current tobacco use decreases have leveled off in recent years - Why? Education & community activities Taxes & policies
More informationTHE IMPORTANCE OF POINT OF SALE
THE IMPORTANCE OF POINT OF SALE Counter Tobacco Allison E. Myers, MPH Kurt M. Ribisl, PhD Adapted from a presentation given January 16, 2013 Office of Smoking and Health Centers for Disease Control and
More informationSocial and Behavioral Sciences for Tobacco Use
Social and Behavioral Sciences for Tobacco Use Bonnie L. Halpern-Felsher, Ph.D., FSAHM Professor Division of Adolescent Medicine Department of Pediatrics Tobacco Decision-Making Theoretical Framework Demographic
More informationIMPACT OF MENTHOL CIGARETTES ON YOUTH SMOKING INITIATION AND HEALTH DISPARITIES
IMPACT OF MENTHOL CIGARETTES ON YOUTH SMOKING INITIATION AND HEALTH DISPARITIES Cigarettes with specific characterizing flavors were prohibited in the U.S. on September 22, 2009, as part of the Family
More informationWHO Framework Convention on Tobacco Control
WHO Framework Convention on Tobacco Control When WHO was established in 1948, its Member States incorporated the power to negotiate treaties into its Constitution. This power remained dormant until 1996,
More informationRJ Reynolds Topic List
RJ Reynolds Topic List ADVERTISEMENTS AMMONIA USE ARTICLES OF INCORPORATION/BY-LAWS BILLBOARD PLACEMENT LOCATION BIOLOGICAL ACTIVITY OF CIGARETTES BIOLOGICAL RESEARCH DIVISION BOARD OF DIRECTORS MEETINGS
More informationconsistent with the industry documents we note in our September letter.
February 18, 2010 Division of Dockets Management (HFA-305) Food and Drug Administration Department of Health and Human Services 5630 Fishers Lane, Room 1061 Rockville, MD 20852 RE: Docket Number FDA-2010-N-0020
More informationCity of Chicago O Office of the City Clerk. Document Tracking Sheet
City of Chicago Office of the City Clerk O2018-7371 Document Tracking Sheet Meeting Date: Sponsor(s): Type: Title: Comrnittee(s) Assignment: 9/20/2018 Dept./Agency Ordinance Amendment of Municipal Code
More informationA REPORT ON THE INCIDENCE AND PREVALENCE OF YOUTH TOBACCO USE IN DELAWARE
A REPORT ON THE INCIDENCE AND PREVALENCE OF YOUTH TOBACCO USE IN DELAWARE RESULTS FROM THE ADMINISTRATION OF THE DELAWARE YOUTH TOBACCO SURVEY IN SPRING 00 Delaware Health and Social Services Division
More informationNebraska Youth Tobacco Survey 2015/2017
Nebraska Youth Tobacco Survey 2015/2017 TABLE OF CONTENTS Introduction... 1 Background... 1 Method... 1 Sampling Frame and Response Rates... 1 Weighting Data... 2 Terms and Definitions... 3 Executive Summary...
More informationCentre for Addictive Behaviours Research. Attitudes to tobacco and e- cigarettes, e-cig ads and ASMs
Centre for Addictive Behaviours Research Attitudes to tobacco and e- cigarettes, e-cig ads and ASMs Rationale E-cigarettes present a lower-harm nicotine delivery system, but this perception is not strong
More informationPolicy Options for the Regulation of Electronic Cigarettes
Policy Options for the Regulation of Electronic Cigarettes Consultation submission Your details This submission was completed by: Address: (name) Mark Forsyth (street/box number) 3 Queens Wharf (town/city)
More informationEffective and Compliance Dates Applicable to Retailers, Manufacturers, Importers, and Distributors of Newly Deemed Tobacco Products
Effective and Compliance Dates Applicable to Retailers, Manufacturers, Importers, and Distributors of Newly Deemed Tobacco Quick Facts Retailers that mix and prepare e-liquids or create or modify vaporizers
More informationRaze-On. Tobacco 101
Raze-On Tobacco 101 Key Messages Most people don t use tobacco Tobacco kills Nicotine is addictive The tobacco industry targets youth Tobacco Use in Teens 80% of adult smokers start before the age of 18
More informationRationale for Establishing Tobacco Product Regulation
Rationale for Establishing Tobacco Product Regulation Erik Dybing, MD, PhD Conference of the Parties Technical Briefing Geneva, 7 February 2006 WHO Strategy for Tobacco Control Preventing uptake of tobacco
More informationFDLI s Enforcement, Litigation, and Compliance Conference. Center for Tobacco Products Office of Compliance and Enforcement 2017 Update
FDLI s Enforcement, Litigation, and Compliance Conference Center for Tobacco Products Office of Compliance and Enforcement 2017 Update Ann Simoneau, Director Office of Compliance and Enforcement Center
More informationTobacco Product Regulation: FDA s Economic Impact Analysis Frank J. Chaloupka University of Illinois at Chicago
Tobacco Product Regulation: FDA s Economic Impact Analysis Frank J. Chaloupka University of Illinois at Chicago American Heart Association/American Stroke Association Advocacy Coordinating Committee Dallas
More informationFDLI Annual Conference
FDLI Annual Conference Panel Tobacco Harm Reduction: Opportunities & Regulatory Pathways to Achieve May 5, 2017 Joe Murillo Vice President, Regulatory Affairs Altria Client Services Panel Discussion at
More informationAre Canadian Smokers Ready for Plain Packaging? Findings from the ITC Four Country Survey,
Are Canadian Smokers Ready for? Findings from the ITC Four Country Survey, 2010 2011 Pete Driezen 1, David Hammond 1, Geoffrey T. Fong 1,2, Hua-Hie Yong 3, Jessica L. Reid 1 1 University of Waterloo 2
More informationPopulation impacts of snus tobacco initiation and cessation
Population impacts of snus tobacco initiation and cessation Karl Lund, Ph.d Research Director, Tobacco Polarcircle Norway Registered sales of tobacco products in Norway 1909-2014 World war II Cigarettes
More informationFlavors Hook Kids. The Tobacco Industry s Kids Menu MARIPOSA COUNTY HEALTH DEPARTMENT
Flavors Hook Kids The Tobacco Industry s Kids Menu Mariposa County Tobacco Education Program We engage with the community to: Create smoke free environments Counter the aggressive marketing practices of
More informationDiscussion points on Bill S-5
Disclaimer: The following document was developed to provide a brief set of discussion points for individuals wishing to discuss Bill S-5 with policy makers, politicians, senators or their advisers. It
More informationTOBACCO PRODUCT OR MEDICAL PRODUCT?
TOBACCO PRODUCT OR MEDICAL PRODUCT? Priscilla Callahan-Lyon, MD Deputy Director Division of Individual Health Science Office of Science, CTP Grail Sipes, JD Director Office of Regulatory Policy, CDER Disclaimer:
More informationSNUS ON THE LOOSE: Big Tobacco s s latest attempt to make nicotine more attractive
SNUS ON THE LOOSE: Big Tobacco s s latest attempt to make nicotine more attractive U.S. Smokeless Tobacco Market Historically the preserve of smaller, specialized companies: Conwood U.S. U.S. Smokeless
More informationAMA Submission House of Representatives Standing Committee on Health and Ageing inquiry into the
AMA Submission House of Representatives Standing Committee on Health and Ageing inquiry into the Tobacco Plain Packaging Bill 2011 Trade Marks Amendment (Tobacco Plain Packaging) Bill 2011 July 2011 As
More informationBill. amending the Tobacco Control Act, No. 6/2002, with subsequent amendments. From the Minister of Health.
146 th Legislative session, 2016 2017. Parliamentary document x x. matter. Government bill. Bill amending the Tobacco Control Act, No. 6/2002, with subsequent amendments. From the Minister of Health. Article
More informationTobacco Use in Adolescents
Tobacco Use in Adolescents Joycelyn Lawrence, MD Leonard Miller School of Medicine at the University of Miami Department of Family Medicine 1 Overview Description: This section will introduce you to the
More informationGLOBAL YOUTH TOBACCO SURVEY
REPORT GLOBAL YOUTH TOBACCO SURVEY Prepared by: Environmental Health Unit P/ Bag 00269 Gaborone TEL: 3975351 FAX: 3974354 E-mail: tmaule@gov.bw TABLE OF CONTENTS 1 Introduction Background Objectives Rationale
More informationMARKETING STANDARDS FOR MEMBERSHIP
MARKETING STANDARDS FOR MEMBERSHIP The Vapor Technology Association (VTA) is a leading national trade association in the electronic cigarette and vapor product industry. VTA represents the manufacturers,
More informationThe Economics of Smoking
The Economics of Smoking One of the potential problems (from an economic perspective) with smoking is that there may be an externality in consumption, so there may be difference between the private and
More informationFDA S CENTER FOR TOBACCO PRODUCTS: AN UPDATE ON REGULATORY ACTIVITIES AND PRIORITIES
FDA S CENTER FOR TOBACCO PRODUCTS: AN UPDATE ON REGULATORY ACTIVITIES AND PRIORITIES Mitch Zeller, J.D. (Director, FDA CTP) Matthew R. Holman, Ph.D. (Director, Office of Science, FDA CTP) Kathy Crosby
More informationWho is Targeting You? The Tobacco Industry Those who want to profit from your smoking
Who is Targeting You? The Tobacco Industry Those who want to profit from your smoking The Tobacco Industry like no other Tobacco is the ONLY legal product sold that is lethal when used exactly as the manufacturer
More informationPolicy Options for the Regulation of Electronic Cigarettes
Policy Options for the Regulation of Electronic Cigarettes Consultation submission Your details This submission was completed by: (name) Philip Hope / Assoc Prof Chris Atkinson Address: (street/box number)
More informationMight Smoking Rates go up in Flames? Dr John Schoonbee, Chief Medical Officer, Swiss Re
Might Smoking Rates go up in Flames? Dr John Schoonbee, Chief Medical Officer, Swiss Re 2 Agenda Smoking is still a problem Stopping is hard Electronic cigarettes Reduced Risk tobacco products Males >15yr
More informationBackground and Analysis Objectives Methods and Approach
Cigarettes, Tobacco Dependence, and Smoking Cessation: Project MOM Final Report Lorraine R. Reitzel, Ph.D., The University of Texas, MD Anderson Cancer Center Background and Analysis Objectives Background.
More informationModified Risk Tobacco Product Applications A Succinct ENDS Industry Perspective
Modified Risk Tobacco Product Applications A Succinct ENDS Industry Perspective Patricia I. Kovacevic General Counsel, Chief Compliance Officer Presentation to the Food and Drug Law Institute Tobacco Conference,
More informationCharacterization of Menthol History and Design of Menthol Cigarettes
Characterization of Menthol History and Design of Menthol Cigarettes Tobacco Products Scientific Advisory Committee July 15, 2010 Michael W. Ogden, Ph.D. Overview History of menthol Cigarette design General
More informationE-CIGARETTE OR DRUG DELIVERY DEVICE?
E-CIGARETTE OR DRUG DELIVERY DEVICE? Schroeder Institute Researchers Raise Questions About Safety, Usage and Future Implications of New Nicotine Delivery Products Release Date: July 20, 2011 Washington,
More informationPresented at FDLI Annual Conference, Washington DC, May 4, 2017, 10:45 to 11:30am 1
Vice President, Research, Health Policy and Abuse Liability Pinney Associates And Professor, Adjunct, Behavioral Biology Department of Psychiatry and Behavioral Sciences The Johns Hopkins University School
More informationActual Use Study of the Potential Reduced-Risk Product (RRP): Tobacco Heating System (THS)
Actual Use Study of the Potential Reduced-Risk Product (RRP): Tobacco Heating System (THS) S. Roulet 1, P. Magnani 1, G. Kallischnigg 2, A. Dugan 3, C. Gage 3, C. Kanitscheider 4, M. Apecechea 4, A. Ramazzotti
More informationRADM Patrick O Carroll, MD, MPH Senior Advisor, Assistant Secretary for Health, US DHSS
Ending the Tobacco Epidemic RADM Patrick O Carroll, MD, MPH Senior Advisor, Assistant Secretary for Health, US DHSS Tim McAfee, MD, MPH Senior Medical Officer, Office on Smoking and Health, CDC www.nwcphp.org/hot-topics
More informationELECTRONIC CIGARETTES WHAT S THE BOTTOM LINE?
ELECTRONIC CIGARETTES WHAT S THE BOTTOM LINE? E-cigarettes have the potential to benefit adult smokers who are not pregnant if used as a complete substitute for regular cigarettes and other smoked tobacco
More informationBurkina Faso. Report card on the WHO Framework Convention on Tobacco Control. 29 October Contents. Introduction
Report card on the WHO Framework Convention on Tobacco Control Burkina Faso Introduction Tobacco use is the single most preventable cause of death in the world today, and is estimated to kill more than
More informationShould FDA try to move smokers to e-cigarettes or other less harmful tobacco-nicotine products and, if so, how?
Should FDA try to move smokers to e-cigarettes or other less harmful tobacco-nicotine products and, if so, how? Jeff Weiss General Counsel/EVP of Gov. Affairs of NJOY, LLC FDLI - October 20, 2017 FDA s
More informationWayne Hall and Coral Gartner University of Queensland
Wayne Hall and Coral Gartner University of Queensland Current policy situation in Australia What is its rationale and how is it defended? An ethical analysis of Current Australian policy A graduated approach
More informationAfter the FDA Tobacco Control Law: Which Policies Are Legal To Pursue?
After the FDA Tobacco Control Law: Which Policies Are Legal To Pursue? October 2009 (Updated July 2010) The passage of the Family Smoking Prevention and Tobacco Control Act (the 2009 FDA Law ) makes it
More informationMODIFIED RISK TOBACCO PRODUCT MARKETING DECISIONS
MODIFIED RISK TOBACCO PRODUCT MARKETING DECISIONS Presented by David Ashley, Ph.D. Rear Admiral (retired), US Public Health Service Director, Office of Science, CTP, FDA Disclaimer: This is not a formal
More informationNIDA/FDA Collaborations
NIDA/FDA Collaborations Wilson M. Compton, M.D., M.P.E. Director, Division of Epidemiology, Services and Prevention Research National Institute on Drug Abuse National Institutes of Health Tobacco use is
More informationChallenges ahead to reach the goal set up in Tobacco End Game 2025
Challenges ahead to reach the goal set up in Tobacco End Game 2025 Dr Vera Luiza da Costa e Silva Head of the Convention Secretariat WHO FCTC 12 June 2018 Towards the end game 1. Where are we? 2. What
More informationSurvey of U.S. Adult Cigarette Smokers
Survey of U.S. Adult Cigarette Smokers Topline Report 13 October 2016 ADULT CIGARETTE SMOKERS (U.S. NATIONWIDE): n=1,000 online surveys S1. First, which of the following ranges includes your age? 0% Under
More informationAddressing the Challenge of ENDS Regulation. David Graham President & Managing Partner Reveritas Group
Addressing the Challenge of ENDS Regulation David Graham President & Managing Partner Reveritas Group Addressing the Challenge of ENDS Regulation 1. The context of conflict and effect of the crossfire
More informationElectronic Cigarettes and the Medical Society
Electronic Cigarettes and the Medical Society Michele Coleman MPH, MPA 2014 WI Medical Society Health Policy Intern LRB 1844 Exempting electronic smoking devices from the types of smoking devices that
More informationThe Effects of E-Cigarette Warning Labels among Yong Adult Non-Smokers. Darren Mays, PhD, MPH Georgetown University
The Effects of E-Cigarette Warning Labels among Yong Adult Non-Smokers Darren Mays, PhD, MPH Georgetown University Acknowledgments Co-Authors Georgetown: Clayton Smith, BA, Andrea Johnson, MPH, CHES, Kenneth
More informationWelcome Superheros! YOUR. Winter Awareness Workshop 2017 BE A HERO IN COMMUNITY!
Welcome Superheros! BE A HERO IN YOUR COMMUNITY! Winter Awareness Workshop 2017 WHAT ARE E-CIGARETTES /VAPING DEVICES? Devices that allow users to inhale aerosol containing nicotine or other substances.
More information16851 Mount Wolfe Road Caledon ON L7E 3P or 1 (855)
2 Copyright 2015, Canadian Network for Respiratory Care 16851 Mount Wolfe Road Caledon ON L7E 3P6 905 880-1092 or 1 (855) 355-4672 www.cnrchome.net www.cnrchome.net Contents 1 Health Promotion and Tobacco
More informationLung Cancer Epidemiology & Prevention. A/Prof Fraser Brims
Lung Cancer Epidemiology & Prevention A/Prof Fraser Brims Introduction Lung cancer burden Global, Australia, WA Current smoking rates Other risks and associations Prevention Tobacco control E-cigarettes
More informationHealth warnings and plain packaging
Health warnings and plain packaging Evidence David Hammond PhD 25 February 13 1 Disclosure Expert Advisory Group on Plain Packaging, n Government Expert Witness on behalf of the Commonwealth of in plain
More informationCreating a Tobacco-Free Scotland: Addressing the Inequalities Challenge
Creating a Tobacco-Free Scotland: Addressing the Inequalities Challenge Amanda Amos Centre for Population Health Sciences University of Edinburgh Outline What are the issues and challenges- patterns and
More informationWhy comprehensive TC is essential for successful harm reduction
Why comprehensive TC is essential for successful harm reduction E-cigarette summit London 15 th November 2018 Deborah Arnott Chief Executive ASH (Action on Smoking and Health) Declaration of Interest ASH
More informationE-Cigs, Etc.: Policy Options for Regulating Nicotine Delivery Devices. Indiana Local Boards of Health Webinar Feb. 12, 2015
E-Cigs, Etc.: Policy Options for Regulating Nicotine Delivery Devices Indiana Local Boards of Health Webinar Feb. 12, 2015 How to Use Webex If you can hear us through your computer, you do not need to
More informationMaryland Tobacco Control Program Successes. Donald Shell, MD, MA Interim Director DHMH, Center for Health Promotion Education, Tobacco Use Prevention
Maryland Tobacco Control Program Successes Donald Shell, MD, MA Interim Director DHMH, Center for Health Promotion Education, Tobacco Use Prevention Monitoring Changing Tobacco Use Behaviors 2000-2010
More informationThe Voice of Local Public Health in New York State. May 12, 2014
The Voice of Local Public Health in New York State May 12, 2014 Testimony before the Senate Standing Committee on Health To consider including electronic cigarettes in the existing Clean Indoor Air Act
More informationEXECUTIVE SUMMARY. 1 P age
EXECUTIVE SUMMARY The Global Adult Tobacco Survey (GATS) is the global standard for systematically monitoring adult tobacco use (smoking and smokeless) and tracking key tobacco control indicators. GATS
More informationTobacco Packages: Ads for tobacco companies or tools for public health?
Tobacco Packages: Ads for tobacco companies or tools for public health? Heather Selin Tobacco Control Advisor, PAHO/WHO 2005 The Importance of the Package To tobacco companies: Critical link between ads
More information